Latest Commercialization News

Green Technology Metals (ASX: GT1) sharpens focus on its Seymour Lithium Project amid a lithium price rebound, key permitting progress, and extended C$100 million financing interest from Export Development Canada.

PTR Minerals delivered standout assay results from its Rosewood Titanium Project, confirming extensive high-grade mineralisation and strong metallurgical performance, keeping its maiden JORC resource estimate on track for Q2 2026.

eMetals Limited has solidified its foothold in high-grade tungsten with a binding acquisition in Utah, while its Ugandan gold projects reveal promising soil anomalies amid ongoing exploration.

Minerals 260 has secured a $59.1 million fixed-price contract with ATCO to build a 400-person accommodation village at its Bullabulling Gold Project, marking a key step towards construction readiness.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Cleo Diagnostics (ASX:COV) has hit a major milestone by completing sample collection for its pivotal U.S. ovarian cancer trial, while progressing manufacturing and analytical validation steps toward FDA 510(k) submission.

Victory Metals has reported record rare earth oxide grades and exceptional metallurgical results at its North Stanmore project, alongside strategic partnerships and heritage clearances that unlock exploration potential.

Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.

Zeotech pushed forward its AusPozz™ metakaolin commercialisation with extended and new MOUs, progressed key Toondoon project approvals amid rising contractor costs, and launched live methane control trials.

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.

Nimy Resources has identified significant extensions to its high-grade gallium deposit at Mons Block 3 and shipped test material to the US as part of a strategic partnership. A scoping study is underway to evaluate mining and processing economics, while regional exploration continues across multiple targets.

Volt Resources has secured a major extension and volume increase to its Bunyu graphite offtake agreement while progressing high purity graphite production and downstream refinery development in the US.